Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
AVANTGEN logo — Premier Partner in Advancing Antibody Drugs

AVANTGEN

Premier Partner in Advancing Antibody Drugs

Founded 2006 United States San Diego, United States 8 employees Biotechnology, Health Care

General Information

Company Name AVANTGEN
Founded Year 2006
Location United States San Diego, United States
Employees 8
Industries Biotechnology, Health Care
Social

BounceWatch is an independent company data service, not affiliated with AVANTGEN. To contact AVANTGEN, visit avantgen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AVANTGEN compare?

A PDF of AVANTGEN and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AVANTGEN soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AVANTGEN

AVANTGEN is a renowned biotechnology company founded in 2006 and based in San Diego, United States. The company's slogan "Premier Partner in Advancing Antibody Drugs" encapsulates its dedication to accelerating antibody-based therapeutics for their scientific partners through innovative platforms. AvantGen's primary focus lies in the biotechnology and healthcare industries.

The latest notable investment in AvantGen occurred on 25 May 2021, in the form of a grant investment from the National Institutes of Health. This injection of funds is a testament to the recognition and support the company is receiving for its pioneering work in the field of antibody-based therapeutics.

AvantGen's collaborative and driven team is steadfast in their pursuit, embodying a fun yet focused approach towards advancing antibody drugs. With its track record and commitment, AvantGen stands as a promising venture in the biotechnology sector, drawing attention from potential investors and partners alike.

Business keywords: Antibody Drugs, Therapeutics, Yeast Display, Antibody Discovery, Antibody Engineering, NK cell engager, Humanization, Affinity Maturation, Biologics, Diagnostic Division, Research, San Diego, Innovation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
National Institute of Health
National Institute of Health
01 May 2021
Grant Undisclosed -
01 Mar 2015

AVANTGEN Alternatives & Competitors

View All Alternatives
AVANTGEN vs
Creative Biolabs
Creative Biolabs United States

Antibody discovery, antibody engineering.

23 employees
Biotechnology, Health Care
AVANTGEN vs
858 Therapeutics
858 Therapeutics United States

Discovering innovative small molecule therapeutics for the treatment of cancer

Venture round
30 employees
Biotechnology, Health Care
AVANTGEN vs
Adimab
Adimab United States

Premier Human Antibody Discovery and Engineering Company

Venture round
137 employees
Biotechnology, Health Care
View all alternatives

FAQ About AVANTGEN

Premier Partner in Advancing Antibody Drugs
AVANTGEN was founded in 2006.
AVANTGEN is headquartered in San Diego, United States.
AVANTGEN operates in Biotechnology and Health Care. Its work centres on Antibody Drugs, Therapeutics, Yeast Display and Antibody Discovery.
AVANTGEN has approximately 8 employees.
AVANTGEN has completed 2 funding rounds.
Top alternatives and competitors to AVANTGEN include Creative Biolabs, 858 Therapeutics, Adimab, RevMAb Biosciences USA, Inc., Biointron. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AVANTGEN and Creative Biolabs are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AVANTGEN, https://bouncewatch.com/company/avantgen, updated 30 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout